APO Research, Inc.

APO RESEARCH · REPORT

Home Parenteral Nutrition (HPN)

Selected research

Market Structure

Global Home Parenteral Nutrition (HPN) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Home Parenteral Nutrition (HPN) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Home Parenteral Nutrition (HPN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Home Parenteral Nutrition (HPN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Home Parenteral Nutrition (HPN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Home Parenteral Nutrition (HPN) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Home Parenteral Nutrition (HPN) include B. Braun Melsungen, Grifols International, Otsuka Pharmaceutical, Sichuan Kelun Pharmaceutical, Teva Pharmaceutical, Baxter, Fresenius Kabi, Pfizer and Takeda, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Home Parenteral Nutrition (HPN) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Home Parenteral Nutrition (HPN) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Home Parenteral Nutrition (HPN) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Home Parenteral Nutrition (HPN) market size, projected growth trends, production technologies, key applications, and end-use industries.

Home Parenteral Nutrition (HPN) Segment by Company

B. Braun Melsungen

Grifols International

Otsuka Pharmaceutical

Sichuan Kelun Pharmaceutical

Teva Pharmaceutical

Baxter

Fresenius Kabi

Pfizer

Takeda

Home Parenteral Nutrition (HPN) Segment by Type

Parenteral Lipid Emulsion

Single Dose Amino Acid Solution

Carbohydrates

Trace Elements

Vitamins and Minerals

Home Parenteral Nutrition (HPN) Segment by Application

Neonates

Chronic Disease Patients

Geriatrics

Home Parenteral Nutrition (HPN) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Home Parenteral Nutrition (HPN) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Home Parenteral Nutrition (HPN) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Home Parenteral Nutrition (HPN).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Home Parenteral Nutrition (HPN) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Home Parenteral Nutrition (HPN) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Home Parenteral Nutrition (HPN) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Home Parenteral Nutrition (HPN) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Home Parenteral Nutrition (HPN) Industry Trends Table 2. Home Parenteral Nutrition (HPN) Industry Drivers Table 3. Home Parenteral Nutrition (HPN) Industry Opportunities and Challenges Table 4. Home Parenteral Nutrition (HPN) Industry Restraints Table 5. Global Home Parenteral Nutrition (HPN) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Home Parenteral Nutrition (HPN) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Home Parenteral Nutrition (HPN) Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Home Parenteral Nutrition (HPN) Sales Market Share by Manufacturers Table 9. Global Home Parenteral Nutrition (HPN) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Home Parenteral Nutrition (HPN) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Home Parenteral Nutrition (HPN) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Home Parenteral Nutrition (HPN) Manufacturers, Product Type & Application Table 13. Global Home Parenteral Nutrition (HPN) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Home Parenteral Nutrition (HPN) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Parenteral Lipid Emulsion Table 17. Major Manufacturers of Single Dose Amino Acid Solution Table 18. Major Manufacturers of Carbohydrates Table 19. Major Manufacturers of Trace Elements Table 20. Major Manufacturers of Vitamins and Minerals Table 21. Global Home Parenteral Nutrition (HPN) Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 22. Global Home Parenteral Nutrition (HPN) Sales by Type (2021-2026) & (K Units) Table 23. Global Home Parenteral Nutrition (HPN) Sales by Type (2027-2032) & (K Units) Table 24. Global Home Parenteral Nutrition (HPN) Sales Market Share by Type (2021-2026) Table 25. Global Home Parenteral Nutrition (HPN) Sales Market Share by Type (2027-2032) Table 26. Global Home Parenteral Nutrition (HPN) Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 27. Global Home Parenteral Nutrition (HPN) Revenue by Type (2021-2026) & (K Units) Table 28. Global Home Parenteral Nutrition (HPN) Revenue by Type (2027-2032) & (K Units) Table 29. Global Home Parenteral Nutrition (HPN) Revenue Market Share by Type (2021-2026) Table 30. Global Home Parenteral Nutrition (HPN) Revenue Market Share by Type (2027-2032) Table 31. Major Manufacturers of Neonates Table 32. Major Manufacturers of Chronic Disease Patients Table 33. Major Manufacturers of Geriatrics Table 34. Global Home Parenteral Nutrition (HPN) Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 35. Global Home Parenteral Nutrition (HPN) Sales by Application (2021-2026) & (K Units) Table 36. Global Home Parenteral Nutrition (HPN) Sales by Application (2027-2032) & (K Units) Table 37. Global Home Parenteral Nutrition (HPN) Sales Market Share by Application (2021-2026) Table 38. Global Home Parenteral Nutrition (HPN) Sales Market Share by Application (2027-2032) Table 39. Global Home Parenteral Nutrition (HPN) Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 40. Global Home Parenteral Nutrition (HPN) Revenue by Application (2021-2026) & (K Units) Table 41. Global Home Parenteral Nutrition (HPN) Revenue by Application (2027-2032) & (K Units) Table 42. Global Home Parenteral Nutrition (HPN) Revenue Market Share by Application (2021-2026) Table 43. Global Home Parenteral Nutrition (HPN) Revenue Market Share by Application (2027-2032) Table 44. Global Home Parenteral Nutrition (HPN) Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 45. Global Home Parenteral Nutrition (HPN) Sales by Region (2021-2026) & (K Units) Table 46. Global Home Parenteral Nutrition (HPN) Sales Market Share by Region (2021-2026) Table 47. Global Home Parenteral Nutrition (HPN) Sales Forecasted by Region (2027-2032) & (K Units) Table 48. Global Home Parenteral Nutrition (HPN) Sales Forecasted Market Share by Region (2027-2032) Table 49. North America Home Parenteral Nutrition (HPN) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. North America Home Parenteral Nutrition (HPN) Sales by Country (2021-2026) & (K Units) Table 51. North America Home Parenteral Nutrition (HPN) Sales by Country (2027-2032) & (K Units) Table 52. Europe Home Parenteral Nutrition (HPN) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Europe Home Parenteral Nutrition (HPN) Sales by Country (2021-2026) & (K Units) Table 54. Europe Home Parenteral Nutrition (HPN) Sales by Country (2027-2032) & (K Units) Table 55. Asia Pacific Home Parenteral Nutrition (HPN) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. Asia Pacific Home Parenteral Nutrition (HPN) Sales by Country (2021-2026) & (K Units) Table 57. Asia Pacific Home Parenteral Nutrition (HPN) Sales by Country (2027-2032) & (K Units) Table 58. South America, Middle East and Africa Home Parenteral Nutrition (HPN) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 59. South America, Middle East and Africa Home Parenteral Nutrition (HPN) Sales by Country (2021-2026) & (K Units) Table 60. South America, Middle East and Africa Home Parenteral Nutrition (HPN) Sales by Country (2027-2032) & (K Units) Table 61. Global Home Parenteral Nutrition (HPN) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 62. Global Home Parenteral Nutrition (HPN) Revenue by Region (2021-2026) & (US$ Million) Table 63. Global Home Parenteral Nutrition (HPN) Revenue by Region (2027-2032) & (US$ Million) Table 64. Global Home Parenteral Nutrition (HPN) Revenue Market Share by Region (2021-2026) Table 65. Global Home Parenteral Nutrition (HPN) Revenue Market Share by Region (2027-2032) Table 66. B. Braun Melsungen Company Information Table 67. B. Braun Melsungen Business Overview Table 68. B. Braun Melsungen Home Parenteral Nutrition (HPN) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 69. B. Braun Melsungen Home Parenteral Nutrition (HPN) Product Portfolio Table 70. B. Braun Melsungen Recent Development Table 71. Grifols International Company Information Table 72. Grifols International Business Overview Table 73. Grifols International Home Parenteral Nutrition (HPN) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 74. Grifols International Home Parenteral Nutrition (HPN) Product Portfolio Table 75. Grifols International Recent Development Table 76. Otsuka Pharmaceutical Company Information Table 77. Otsuka Pharmaceutical Business Overview Table 78. Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 79. Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio Table 80. Otsuka Pharmaceutical Recent Development Table 81. Sichuan Kelun Pharmaceutical Company Information Table 82. Sichuan Kelun Pharmaceutical Business Overview Table 83. Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 84. Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio Table 85. Sichuan Kelun Pharmaceutical Recent Development Table 86. Teva Pharmaceutical Company Information Table 87. Teva Pharmaceutical Business Overview Table 88. Teva Pharmaceutical Home Parenteral Nutrition (HPN) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 89. Teva Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio Table 90. Teva Pharmaceutical Recent Development Table 91. Baxter Company Information Table 92. Baxter Business Overview Table 93. Baxter Home Parenteral Nutrition (HPN) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 94. Baxter Home Parenteral Nutrition (HPN) Product Portfolio Table 95. Baxter Recent Development Table 96. Fresenius Kabi Company Information Table 97. Fresenius Kabi Business Overview Table 98. Fresenius Kabi Home Parenteral Nutrition (HPN) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 99. Fresenius Kabi Home Parenteral Nutrition (HPN) Product Portfolio Table 100. Fresenius Kabi Recent Development Table 101. Pfizer Company Information Table 102. Pfizer Business Overview Table 103. Pfizer Home Parenteral Nutrition (HPN) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 104. Pfizer Home Parenteral Nutrition (HPN) Product Portfolio Table 105. Pfizer Recent Development Table 106. Takeda Company Information Table 107. Takeda Business Overview Table 108. Takeda Home Parenteral Nutrition (HPN) Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 109. Takeda Home Parenteral Nutrition (HPN) Product Portfolio Table 110. Takeda Recent Development Table 111. Key Raw Materials Table 112. Raw Materials Key Suppliers Table 113. Home Parenteral Nutrition (HPN) Distributors List Table 114. Home Parenteral Nutrition (HPN) Customers List Table 115. Research Programs/Design for This Report Table 116. Authors List of This Report Table 117. Secondary Sources Table 118. Primary Sources List of Figures Figure 1. Home Parenteral Nutrition (HPN) Product Image Figure 2. Global Home Parenteral Nutrition (HPN) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Home Parenteral Nutrition (HPN) Market Size (2021-2032) & (US$ Million) Figure 4. Global Home Parenteral Nutrition (HPN) Sales (2021-2032) & (K Units) Figure 5. Global Home Parenteral Nutrition (HPN) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Home Parenteral Nutrition (HPN) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Parenteral Lipid Emulsion Image Figure 9. Single Dose Amino Acid Solution Image Figure 10. Carbohydrates Image Figure 11. Trace Elements Image Figure 12. Vitamins and Minerals Image Figure 13. Global Home Parenteral Nutrition (HPN) Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Home Parenteral Nutrition (HPN) Sales Market Share 2021 VS 2025 VS 2032 Figure 15. Global Home Parenteral Nutrition (HPN) Sales Market Share by Type (2021-2032) Figure 16. Global Home Parenteral Nutrition (HPN) Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 17. Global Home Parenteral Nutrition (HPN) Revenue Market Share 2021 VS 2025 VS 2032 Figure 18. Global Home Parenteral Nutrition (HPN) Revenue Market Share by Type (2021-2032) Figure 19. Neonates Image Figure 20. Chronic Disease Patients Image Figure 21. Geriatrics Image Figure 22. Global Home Parenteral Nutrition (HPN) Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Home Parenteral Nutrition (HPN) Sales Market Share 2021 VS 2025 VS 2032 Figure 24. Global Home Parenteral Nutrition (HPN) Sales Market Share by Application (2021-2032) Figure 25. Global Home Parenteral Nutrition (HPN) Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 26. Global Home Parenteral Nutrition (HPN) Revenue Market Share 2021 VS 2025 VS 2032 Figure 27. Global Home Parenteral Nutrition (HPN) Revenue Market Share by Application (2021-2032) Figure 28. North America Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 29. North America Home Parenteral Nutrition (HPN) Sales Market Share by Country (2021-2032) Figure 30. U.S. Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Canada Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Mexico Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 33. Europe Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 34. Europe Home Parenteral Nutrition (HPN) Sales Market Share by Country (2021-2032) Figure 35. Germany Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 36. France Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 37. U.K. Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Italy Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Netherlands Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Asia Pacific Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Asia Pacific Home Parenteral Nutrition (HPN) Sales Market Share by Country (2021-2032) Figure 42. China Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Japan Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 44. South Korea Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Southeast Asia Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 46. India Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Australia Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South America, Middle East and Africa Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South America, Middle East and Africa Home Parenteral Nutrition (HPN) Sales Market Share by Country (2021-2032) Figure 50. Brazil Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 51. South Africa Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Saudi Arabia Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Turkey Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Argentina Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 55. UAE Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Egypt Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Chile Home Parenteral Nutrition (HPN) Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Global Home Parenteral Nutrition (HPN) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 59. Global Home Parenteral Nutrition (HPN) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 60. North America Home Parenteral Nutrition (HPN) Revenue (2021-2032) & (US$ Million) Figure 61. North America Home Parenteral Nutrition (HPN) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Europe Home Parenteral Nutrition (HPN) Revenue (2021-2032) & (US$ Million) Figure 63. Europe Home Parenteral Nutrition (HPN) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. Asia-Pacific Home Parenteral Nutrition (HPN) Revenue (2021-2032) & (US$ Million) Figure 65. Asia-Pacific Home Parenteral Nutrition (HPN) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. South America, Middle East and Africa Home Parenteral Nutrition (HPN) Revenue (2021-2032) & (US$ Million) Figure 67. South America, Middle East and Africa Home Parenteral Nutrition (HPN) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Home Parenteral Nutrition (HPN) Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Home Parenteral Nutrition (HPN) Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Parenteral Lipid Emulsion
  • Single Dose Amino Acid Solution
  • Carbohydrates
  • Trace Elements
  • Vitamins and Minerals
Applications
  • Neonates
  • Chronic Disease Patients
  • Geriatrics
Companies covered
  • B. Braun Melsungen
  • Grifols International
  • Otsuka Pharmaceutical
  • Sichuan Kelun Pharmaceutical
  • Teva Pharmaceutical
  • Baxter
  • Fresenius Kabi
  • Pfizer
  • Takeda

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Home Parenteral Nutrition (HPN) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Home Parenteral Nutrition (HPN) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Home Parenteral Nutrition (HPN) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Home Parenteral Nutrition (HPN) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Home Parenteral Nutrition (HPN) Market Dynamics
  1. 2.1 Home Parenteral Nutrition (HPN) Industry Trends
  2. 2.2 Home Parenteral Nutrition (HPN) Industry Drivers
  3. 2.3 Home Parenteral Nutrition (HPN) Industry Opportunities and Challenges
  4. 2.4 Home Parenteral Nutrition (HPN) Industry Restraints
3 Home Parenteral Nutrition (HPN) Market by Manufacturers
  1. 3.1 Global Home Parenteral Nutrition (HPN) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Home Parenteral Nutrition (HPN) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Home Parenteral Nutrition (HPN) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Home Parenteral Nutrition (HPN) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Home Parenteral Nutrition (HPN) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Home Parenteral Nutrition (HPN) Manufacturers, Product Type & Application
  7. 3.7 Global Home Parenteral Nutrition (HPN) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Home Parenteral Nutrition (HPN) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Home Parenteral Nutrition (HPN) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Home Parenteral Nutrition (HPN) Tier 1, Tier 2, and Tier 3
4 Home Parenteral Nutrition (HPN) Market by Type
  1. 4.1 Home Parenteral Nutrition (HPN) Type Introduction
  2. 4.1.1 Parenteral Lipid Emulsion
  3. 4.1.2 Single Dose Amino Acid Solution
  4. 4.1.3 Carbohydrates
  5. 4.1.4 Trace Elements
  6. 4.1.5 Vitamins and Minerals
  7. 4.2 Global Home Parenteral Nutrition (HPN) Sales by Type
  8. 4.2.1 Global Home Parenteral Nutrition (HPN) Sales by Type (2021 VS 2025 VS 2032)
  9. 4.2.2 Global Home Parenteral Nutrition (HPN) Sales by Type (2021-2032)
  10. 4.2.3 Global Home Parenteral Nutrition (HPN) Sales Market Share by Type (2021-2032)
  11. 4.3 Global Home Parenteral Nutrition (HPN) Revenue by Type
  12. 4.3.1 Global Home Parenteral Nutrition (HPN) Revenue by Type (2021 VS 2025 VS 2032)
  13. 4.3.2 Global Home Parenteral Nutrition (HPN) Revenue by Type (2021-2032)
  14. 4.3.3 Global Home Parenteral Nutrition (HPN) Revenue Market Share by Type (2021-2032)
5 Home Parenteral Nutrition (HPN) Market by Application
  1. 5.1 Home Parenteral Nutrition (HPN) Application Introduction
  2. 5.1.1 Neonates
  3. 5.1.2 Chronic Disease Patients
  4. 5.1.3 Geriatrics
  5. 5.2 Global Home Parenteral Nutrition (HPN) Sales by Application
  6. 5.2.1 Global Home Parenteral Nutrition (HPN) Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Home Parenteral Nutrition (HPN) Sales by Application (2021-2032)
  8. 5.2.3 Global Home Parenteral Nutrition (HPN) Sales Market Share by Application (2021-2032)
  9. 5.3 Global Home Parenteral Nutrition (HPN) Revenue by Application
  10. 5.3.1 Global Home Parenteral Nutrition (HPN) Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Home Parenteral Nutrition (HPN) Revenue by Application (2021-2032)
  12. 5.3.3 Global Home Parenteral Nutrition (HPN) Revenue Market Share by Application (2021-2032)
6 Global Home Parenteral Nutrition (HPN) Sales by Region
  1. 6.1 Global Home Parenteral Nutrition (HPN) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Home Parenteral Nutrition (HPN) Sales by Region (2021-2032)
  3. 6.2.1 Global Home Parenteral Nutrition (HPN) Sales by Region (2021-2026)
  4. 6.2.2 Global Home Parenteral Nutrition (HPN) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Home Parenteral Nutrition (HPN) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Home Parenteral Nutrition (HPN) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Home Parenteral Nutrition (HPN) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Home Parenteral Nutrition (HPN) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Home Parenteral Nutrition (HPN) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Home Parenteral Nutrition (HPN) Revenue by Region
  1. 7.1 Global Home Parenteral Nutrition (HPN) Revenue by Region
  2. 7.1.1 Global Home Parenteral Nutrition (HPN) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Home Parenteral Nutrition (HPN) Revenue by Region (2021-2026)
  4. 7.1.3 Global Home Parenteral Nutrition (HPN) Revenue by Region (2027-2032)
  5. 7.1.4 Global Home Parenteral Nutrition (HPN) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Home Parenteral Nutrition (HPN) Revenue (2021-2032)
  8. 7.2.2 North America Home Parenteral Nutrition (HPN) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Home Parenteral Nutrition (HPN) Revenue (2021-2032)
  11. 7.3.2 Europe Home Parenteral Nutrition (HPN) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Home Parenteral Nutrition (HPN) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Home Parenteral Nutrition (HPN) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Home Parenteral Nutrition (HPN) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Home Parenteral Nutrition (HPN) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 B. Braun Melsungen
  2. 8.1.1 B. Braun Melsungen Company Information
  3. 8.1.2 B. Braun Melsungen Business Overview
  4. 8.1.3 B. Braun Melsungen Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 B. Braun Melsungen Home Parenteral Nutrition (HPN) Product Portfolio
  6. 8.1.5 B. Braun Melsungen Recent Developments
  7. 8.2 Grifols International
  8. 8.2.1 Grifols International Company Information
  9. 8.2.2 Grifols International Business Overview
  10. 8.2.3 Grifols International Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Grifols International Home Parenteral Nutrition (HPN) Product Portfolio
  12. 8.2.5 Grifols International Recent Developments
  13. 8.3 Otsuka Pharmaceutical
  14. 8.3.1 Otsuka Pharmaceutical Company Information
  15. 8.3.2 Otsuka Pharmaceutical Business Overview
  16. 8.3.3 Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Otsuka Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
  18. 8.3.5 Otsuka Pharmaceutical Recent Developments
  19. 8.4 Sichuan Kelun Pharmaceutical
  20. 8.4.1 Sichuan Kelun Pharmaceutical Company Information
  21. 8.4.2 Sichuan Kelun Pharmaceutical Business Overview
  22. 8.4.3 Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Sichuan Kelun Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
  24. 8.4.5 Sichuan Kelun Pharmaceutical Recent Developments
  25. 8.5 Teva Pharmaceutical
  26. 8.5.1 Teva Pharmaceutical Company Information
  27. 8.5.2 Teva Pharmaceutical Business Overview
  28. 8.5.3 Teva Pharmaceutical Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Teva Pharmaceutical Home Parenteral Nutrition (HPN) Product Portfolio
  30. 8.5.5 Teva Pharmaceutical Recent Developments
  31. 8.6 Baxter
  32. 8.6.1 Baxter Company Information
  33. 8.6.2 Baxter Business Overview
  34. 8.6.3 Baxter Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Baxter Home Parenteral Nutrition (HPN) Product Portfolio
  36. 8.6.5 Baxter Recent Developments
  37. 8.7 Fresenius Kabi
  38. 8.7.1 Fresenius Kabi Company Information
  39. 8.7.2 Fresenius Kabi Business Overview
  40. 8.7.3 Fresenius Kabi Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Fresenius Kabi Home Parenteral Nutrition (HPN) Product Portfolio
  42. 8.7.5 Fresenius Kabi Recent Developments
  43. 8.8 Pfizer
  44. 8.8.1 Pfizer Company Information
  45. 8.8.2 Pfizer Business Overview
  46. 8.8.3 Pfizer Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Pfizer Home Parenteral Nutrition (HPN) Product Portfolio
  48. 8.8.5 Pfizer Recent Developments
  49. 8.9 Takeda
  50. 8.9.1 Takeda Company Information
  51. 8.9.2 Takeda Business Overview
  52. 8.9.3 Takeda Home Parenteral Nutrition (HPN) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Takeda Home Parenteral Nutrition (HPN) Product Portfolio
  54. 8.9.5 Takeda Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Home Parenteral Nutrition (HPN) Value Chain Analysis
  2. 9.1.1 Home Parenteral Nutrition (HPN) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Home Parenteral Nutrition (HPN) Production Mode & Process
  6. 9.2 Home Parenteral Nutrition (HPN) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Home Parenteral Nutrition (HPN) Distributors
  9. 9.2.3 Home Parenteral Nutrition (HPN) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.